Critically ill Covid-19 patients more likely to die in Africa – including SA – than in other regions news24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news24.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
INDIANAPOLIS, May 20, 2021 /PRNewswire/ Tirzepatide led to superior A1C and body weight reductions from baseline across all three doses in adults with type 2 diabetes who have increased cardiovascular (CV) risk compared to titrated insulin glargine in topline results from Eli Lilly and Company s (NYSE: LLY) SURPASS-4 clinical trial. For the efficacy estimand
i, the highest dose of tirzepatide led to an A1C reduction of 2.58 percent and reduced body weight by 11.7 kg (25.8 lb., 13.0 percent) compared to results for those treated with insulin glargine (A1C reduction of 1.44 percent and weight gain of 1.9 kg [4.2 lb., 2.2 percent]) at 52 weeks.
University of Hawaiʻi
How many Native Hawaiians have a health condition called “metabolic syndrome,” a cluster of the most dangerous risk factors for having a heart attack or stroke? The answer is complicated because there are several different ways doctors can diagnose people with metabolic syndrome, and risk factors include high cholesterol, high blood pressure, raised glucose levels and a large waistline. New research from the University of Hawaiʻi at Mānoa shows that Native Hawaiians are particularly affected by which definition doctors use.
Thompson School of Social Work & Public Health researchers, led by recent bachelor’s degree graduate Chloe Asato, examined data on about 1,500 Caucasian, Filipino, Native Hawaiian and Japanese residents of Kohala on Hawaiʻi Island. The data were gathered as part of The Native Hawaiian/Multiethnic Health Research project and findings were published in Metabolic Syndrome and Related Disorders.
Self-injection Device Market: Asia Pacific to Show Promising Growth biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.